FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:183-184 July 20, 1995 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Patients with rheumatoid arthritis have symmetric synovitis of their peripheral joints and various degrees of joint destruction. In short-term studies, slow-acting antirheumatic drugs relieve symptoms and retard joint destruction, but many patients continue to have pain, stiffness, fatigue, and progressive disability.¹ Better treatments are needed. This issue of the Journal includes reports of two randomized, controlled trials that investigated variations of widely used treatments for rheumatoid arthritis.^2,3

In a six-month study of 148 patients with severe rheumatoid arthritis who had had only partial improvement with methotrexate, Tugwell et al. found greater clinical improvement with cyclosporine and methotrexate combined than with . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lindegaard, H, Vallo, J, Horslev-Petersen, K, Junker, P, Ostergaard, M (2001). Low field dedicated magnetic resonance imaging in untreated rheumatoid arthritis of recent onset. Ann Rheum Dis 60: 770-776 [Abstract] [Full Text]